ConnectiCare Rolls Out ScreenRx Program

Prescription drugs remain a hot topic as drug costs continue to rise nearing $500 billion dollars (2015 data) in the United States.  When it comes to specialty drug spend, around 1.5% of members using specialty drugs account for around 42% of drug costs.

Connecticare and ESI continue to roll out innovative, behind the scene programs, impacting members leading to better adherence to high cost medication, decreasing waste and improving health conditions when a member is using a high cost specialty medication.  Please take a moment and review the attached document which outlines the ScreenRx program; ESI/ Connecticare’s proprietary screening solution which combines early detection with tailored interventions to increase patient adherence and healthcare savings.

Are You a ConnectiCare Member?  Bookmark their Updates & Reminders Page

 

---